对于治疗胃癌的新辅助免疫疗法的现状
Xijie Zhang1, Bo Liu1, Rui Wang1
1The Second Clinical Medical School, Lanzhou University, Lanzhou, China.
概括
新辅助免疫疗法对局部发达的胃癌具有前景,旨在改善结果. 目前正在进行研究,以完善这些治疗方法并降低复发率,以改善患者的生存率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 胃癌的全球发病率和死亡率很高.
- 手术可以改善局部晚期疾病的预后,但复发和低于最佳生存率仍然存在.
- 免疫疗法提供了一种新的治疗方法,在晚期胃癌中具有验证的疗效.
研究的目的:
- 总结胃癌新辅助免疫疗法的研究进展和争议.
- 为优化接受新辅助免疫治疗的患者的临床益处.
- 为了完善新辅助免疫疗法方案.
主要方法:
- 文献综述包括PubMed,谷歌学者,科学网和clinicaltrials.gov.gov. 这三种网站.
- 包括指导方针,共识,元分析,临床试验和评论.
- 专注于到2024年1月发布的本地晚期胃癌.
主要成果:
- 免疫疗法越来越多地被纳入了晚期胃癌的治疗指南.
- 目前正在进行的全球研究正在探索新辅助免疫治疗的应用.
- 这项研究综合了关于新辅助免疫疗法的作用和挑战的当前知识.
结论:
- 新辅助免疫疗法是改善胃癌治疗的关键研究领域.
- 为了最大限度地提高临床益处,需要进一步完善治疗方案.
- 解决争议对于优化患者治疗结果至关重要.
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:30Cancer Vaccines
365
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
365
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
162
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
162
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K